EXEL Next Earnings Date Notes

— Exelixis (EXEL) is a biotechnology company focused on discovering, developing, and commercializing innovative therapies for cancer. The company's flagship product is CABOMETYX�ae (cabozantinib), approved for multiple oncology indications including renal cell carcinoma and hepatocellular carcinoma in the U.S. & internationally. Additional revenues stem from collaborations & licensing agreements with pharmaceutical companies such as Ipsen and Takeda, related to cabozantinib's development & commercialization outside the U.S. For investors, it’s important to monitor product revenues (especially CABOMETYX�ae sales), R&D expenses, and updates on the clinical pipeline, as expansion into new indications or positive late-stage trial results can significantly impact long-term growth. Other key metrics include international royalties, operating income margins, and partnership milestones or upfront payments. On the earnings call, listen for management’s guidance on future product launches, regulatory updates, and competitive positioning within the evolving oncology space—all of which can affect Exelixis’ long-term potential. The next projected earnings date for EXEL is 11/3/2026 after close (stay tuned for a confirmed earnings date once announced).

EXEL Next Earnings Date FAQ

On this page we presented the EXEL Next Earnings Date information for Exelixis along with recent past earnings dates. For Q2 of 2026, EXEL reported earnings of 0.910/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, EXEL reported earnings of 0.870/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, EXEL reported earnings of 0.940/share, with the earnings report taking place on 2/10/2026. For Q3 of 2025, EXEL reported earnings of 0.780/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, EXEL reported earnings of 0.750/share, with the earnings report taking place on 7/28/2025. Based on these past earnings dates, the projected next earnings date for EXEL is 11/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Exelixis. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Exelixis shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Exelixis next earnings dates as well as any other stock out there in our coverage universe, to see when the next EXEL earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up EXEL's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the EXEL next earnings date.